Wrays would like to congratulate its client, iCeutica, on its success receiving US FDA approval for the pain drug, ZORVOLEX™ (diclofenac), which uses iCeutica’s SoluMatrix Fine Particle Technology™.
Read more here
Industry Insights
Wrays would like to congratulate its client, iCeutica, on its success receiving US FDA approval for the pain drug, ZORVOLEX™ (diclofenac), which uses iCeutica’s SoluMatrix Fine Particle Technology™.
Read more here